Corcept Therapeutics
$25.159876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$25.15
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.41 (-1.60%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell CORT and other stocks, options, and ETFs commission-free!
About CORT
Corcept Therapeutics Incorporated Common Stock, also called Corcept Therapeutics, is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA. The listed name for CORT is Corcept Therapeutics Incorporated Common Stock.
CEO
Joseph K. Belanoff
Employees
236
Headquarters
Menlo Park, California
Founded
1998
Market Cap
3.04B
Price-Earnings Ratio
29.94
Dividend Yield
—
Average Volume
651.73K
High Today
$25.87
Low Today
$24.77
Open Price
$25.63
Volume
788.11K
52 Week High
$31.18
52 Week Low
$9.70
CORT Earnings
$0.18
$0.23
$0.29
$0.34
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
$0.19 per share
Actual
$0.27 per share